{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:32:05Z","timestamp":1758893525711,"version":"3.41.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Technological Innovation Program of Suzhou Medical and Health","award":["SKY2022135"],"award-info":[{"award-number":["SKY2022135"]}]},{"name":"Priority Academic Program Development of the Jiangsu Higher Education Institutes","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-025-03059-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:45:38Z","timestamp":1751373938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of an ensemble prediction model for acute graft-versus-host disease in allogeneic transplantation based on machine learning"],"prefix":"10.1186","volume":"25","author":[{"given":"Lin","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"8","key":"3059_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425250903107764","volume":"5","author":"JS McCune","year":"2009","unstructured":"McCune JS, Holmberg LA. Busulfan in hematopoietic stem cell transplant setting. Expert Opin Drug Metab Toxicol. 2009;5(8):957\u201369.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"3059_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute Graft-versus-Host disease clinical data collection: A report from the Mount Sinai acute GVHD international consortium. Biol Blood Marrow Transpl. 2016;22(1):4\u201310.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"3059_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers ME, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119(1):296\u2013307.","journal-title":"Blood"},{"issue":"4","key":"3059_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/bmt.2012.187","volume":"48","author":"SE Lee","year":"2013","unstructured":"Lee SE, Cho BS, Kim JH, et al. Risk and prognostic factors for acute GVHD based on NIH consensus criteria. Bone Marrow Transpl. 2013;48(4):587\u201392.","journal-title":"Bone Marrow Transpl"},{"key":"3059_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.12659\/AOT.901495","volume":"22","author":"F Wang","year":"2017","unstructured":"Wang F, Cai B, Wang L, et al. Risk factors for acute Graft-Versus-Host disease after allogeneic Haematopoietic stem cell transplantation: A Single-Center experience. Ann Transpl. 2017;22:58\u201365.","journal-title":"Ann Transpl"},{"issue":"4","key":"3059_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12288-014-0499-5","volume":"31","author":"A Gupta","year":"2015","unstructured":"Gupta A, Punatar S, Gawande J, et al. Risk factors, pattern and clinical outcome of acute graft versus host disease in acute leukemia patients undergoing allogeneic stem cell transplant. Indian J Hematol Blood Transfus. 2015;31(4):404\u201312.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"4","key":"3059_CR7","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/cts.12982","volume":"14","author":"M Phan","year":"2021","unstructured":"Phan M, Chavan R, Beuttler R, et al. Evaluating risk factors for acute graft versus host disease in pediatric hematopoietic stem cell transplant patients receiving tacrolimus. Clin Transl Sci. 2021;14(4):1303\u201313.","journal-title":"Clin Transl Sci"},{"issue":"4","key":"3059_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.21873\/anticanres.11483","volume":"37","author":"S Nassereddine","year":"2017","unstructured":"Nassereddine S, Rafei H, Elbahesh E, Tabbara I. Acute graft versus host disease: A comprehensive review. Anticancer Res. 2017;37(4):1547\u201355.","journal-title":"Anticancer Res"},{"key":"3059_CR9","doi-asserted-by":"crossref","unstructured":"Funke VA, Moreira MC, Vigorito AC. Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation. Rev Assoc Med Bras (1992). 2016;62 Suppl 1:44\u201350.","DOI":"10.1590\/1806-9282.62.suppl1.44"},{"issue":"1","key":"3059_CR10","first-page":"16","volume":"11","author":"J Wojnar","year":"2006","unstructured":"Wojnar J, Giebel S, Krawczyk-Kulis M, et al. Acute graft-versus-host disease. The incidence and risk factors. Ann Transpl. 2006;11(1):16\u201323.","journal-title":"Ann Transpl"},{"issue":"35","key":"3059_CR11","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1200\/JCO.2008.17.6545","volume":"26","author":"T Hahn","year":"2008","unstructured":"Hahn T, McCarthy PL Jr., Zhang MJ, et al. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol. 2008;26(35):5728\u201334.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3059_CR12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","volume":"94","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Smith TL, Folloder J, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999;94(4):1465\u201370.","journal-title":"Blood"},{"issue":"3","key":"3059_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbmt.2017.11.026","volume":"24","author":"A Stikvoort","year":"2018","unstructured":"Stikvoort A, Gaballa A, Solders M, et al. Risk factors for severe acute graft-versus-Host disease in donor graft composition. Biol Blood Marrow Transpl. 2018;24(3):467\u201377.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"3059_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0040-1709150","volume":"58","author":"C Salehnasab","year":"2019","unstructured":"Salehnasab C, Hajifathali A, Asadi F, Roshandel E, Kazemi A, Roshanpoor A. Machine learning classification algorithms to predict aGvHD following Allo-HSCT: A systematic review. Methods Inf Med. 2019;58(6):205\u201312.","journal-title":"Methods Inf Med"},{"issue":"6","key":"3059_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","volume":"284","author":"GS Handelman","year":"2018","unstructured":"Handelman GS, Kok HK, Chandra RV, Razavi AH, Lee MJ, Asadi H. eDoctor: machine learning and the future of medicine. J Intern Med. 2018;284(6):603\u201319.","journal-title":"J Intern Med"},{"key":"3059_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3389\/fphar.2019.01155","volume":"10","author":"X Mo","year":"2019","unstructured":"Mo X, Chen X, Li H, et al. Early and accurate prediction of clinical response to methotrexate treatment in juvenile idiopathic arthritis using machine learning. Front Pharmacol. 2019;10:1155.","journal-title":"Front Pharmacol"},{"issue":"7","key":"3059_CR17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jval.2019.02.012","volume":"22","author":"P Doupe","year":"2019","unstructured":"Doupe P, Faghmous J, Basu S. Machine learning for health services researchers. Value Health. 2019;22(7):808\u201315.","journal-title":"Value Health"},{"issue":"4","key":"3059_CR18","doi-asserted-by":"publisher","first-page":"e0195875","DOI":"10.1371\/journal.pone.0195875","volume":"13","author":"M Nishio","year":"2018","unstructured":"Nishio M, Nishizawa M, Sugiyama O, et al. Computer-aided diagnosis of lung nodule using gradient tree boosting and bayesian optimization. PLoS ONE. 2018;13(4):e0195875.","journal-title":"PLoS ONE"},{"issue":"4","key":"3059_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/jnc.14316","volume":"145","author":"F Maass","year":"2018","unstructured":"Maass F, Michalke B, Leha A, et al. Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of parkinson\u2019s disease. J Neurochem. 2018;145(4):342\u201351.","journal-title":"J Neurochem"},{"issue":"1","key":"3059_CR20","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/s41598-018-19426-7","volume":"8","author":"X Yang","year":"2018","unstructured":"Yang X, De Andrade V, Scullin W, et al. Low-dose x-ray tomography through a deep convolutional neural network. Sci Rep. 2018;8(1):2575.","journal-title":"Sci Rep"},{"key":"3059_CR21","doi-asserted-by":"publisher","first-page":"43270","DOI":"10.1038\/srep43270","volume":"7","author":"JY Park","year":"2017","unstructured":"Park JY, Na HK, Kim S, et al. Robust identification of alzheimer\u2019s disease subtypes based on cortical atrophy patterns. Sci Rep. 2017;7:43270.","journal-title":"Sci Rep"},{"key":"3059_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.media.2018.01.002","volume":"45","author":"KH Thung","year":"2018","unstructured":"Thung KH, Yap PT, Adeli E, Lee SW, Shen D. Alzheimer\u2019s disease neuroimaging I. Conversion and time-to-conversion predictions of mild cognitive impairment using low-rank affinity pursuit denoising and matrix completion. Med Image Anal. 2018;45:68\u201382.","journal-title":"Med Image Anal"},{"issue":"1","key":"3059_CR23","doi-asserted-by":"publisher","first-page":"e0190610","DOI":"10.1371\/journal.pone.0190610","volume":"13","author":"C Lee","year":"2018","unstructured":"Lee C, Haneuse S, Wang HL, et al. Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation. PLoS ONE. 2018;13(1):e0190610.","journal-title":"PLoS ONE"},{"issue":"22","key":"3059_CR24","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1182\/bloodadvances.2019000934","volume":"3","author":"Y Arai","year":"2019","unstructured":"Arai Y, Kondo T, Fuse K, et al. Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. Blood Adv. 2019;3(22):3626\u201334.","journal-title":"Blood Adv"},{"key":"3059_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1200\/CCI.19.00105","volume":"4","author":"S Tang","year":"2020","unstructured":"Tang S, Chappell GT, Mazzoli A, Tewari M, Choi SW, Wiens J. Predicting acute Graft-Versus-Host disease using machine learning and longitudinal vital sign data from electronic health records. JCO Clin Cancer Inf. 2020;4:128\u201335.","journal-title":"JCO Clin Cancer Inf"},{"issue":"3","key":"3059_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s43588-022-00213-4","volume":"2","author":"X Liu","year":"2022","unstructured":"Liu X, Cao Y, Guo Y, et al. Dynamic forecasting of severe acute graft-versus-host disease after transplantation. Nat Comput Sci. 2022;2(3):153\u20139.","journal-title":"Nat Comput Sci"},{"issue":"10","key":"3059_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/ajh.26671","volume":"97","author":"L Eisenberg","year":"2022","unstructured":"Eisenberg L, XplOit c, Brossette C, et al. Time-dependent prediction of mortality and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation using machine learning. Am J Hematol. 2022;97(10):1309\u201323.","journal-title":"Am J Hematol"},{"issue":"1","key":"3059_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbmt.2009.08.010","volume":"16","author":"F Malard","year":"2010","unstructured":"Malard F, Szydlo RM, Brissot E, et al. Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transpl. 2010;16(1):28\u201334.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"3059_CR29","doi-asserted-by":"publisher","first-page":"e6833","DOI":"10.1002\/cam4.6833","volume":"13","author":"K Och","year":"2024","unstructured":"Och K, Turki AT, Gotz KM, et al. A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation. Cancer Med. 2024;13(1):e6833.","journal-title":"Cancer Med"},{"issue":"4","key":"3059_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41409-022-01598-6","volume":"57","author":"J Heritier","year":"2022","unstructured":"Heritier J, Medinger M, Heim D, et al. Optimized cyclosporine starting dose May reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study. Bone Marrow Transpl. 2022;57(4):613\u20139.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"3059_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Chen J, Han MZ, et al. The consensus from the Chinese society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol. 2021;14(1):145.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"3059_CR32","first-page":"529","volume":"41","author":"Stem Cell Application Group CSoHCMA","year":"2020","unstructured":"Stem Cell Application Group CSoHCMA. [Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (III) -acute graft-versus-host disease (2020)]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(7):529\u201336.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"4","key":"3059_CR33","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","volume":"4","author":"R Admiraal","year":"2017","unstructured":"Admiraal R, Nierkens S, de Witte MA, et al. Association between anti-thymocyte Globulin exposure and survival outcomes in adult unrelated Haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis. Lancet Haematol. 2017;4(4):e183\u201391.","journal-title":"Lancet Haematol"},{"issue":"11","key":"3059_CR34","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, et al. EBMT-NIH-CIBMTR task force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transpl. 2018;53(11):1401\u201315.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"3059_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijmedinf.2006.11.006","volume":"77","author":"R Bellazzi","year":"2008","unstructured":"Bellazzi R, Zupan B. Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inf. 2008;77(2):81\u201397.","journal-title":"Int J Med Inf"},{"issue":"1","key":"3059_CR36","doi-asserted-by":"publisher","first-page":"107175","DOI":"10.1016\/j.ijantimicag.2024.107175","volume":"64","author":"LW Chiu","year":"2024","unstructured":"Chiu LW, Ku YE, Chan FY, et al. Machine learning algorithms to predict colistin-induced nephrotoxicity from electronic health records in patients with multidrug-resistant gram-negative infection. Int J Antimicrob Agents. 2024;64(1):107175.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3059_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00277-018-3577-1","volume":"98","author":"M Bianchi","year":"2019","unstructured":"Bianchi M, Heim D, Lengerke C, et al. Cyclosporine levels\u2009>\u2009195 mug\/l on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2019;98(4):971\u20137.","journal-title":"Ann Hematol"},{"issue":"10","key":"3059_CR38","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/bmt.2016.142","volume":"51","author":"SR Marino","year":"2016","unstructured":"Marino SR, Lee SM, Binkowski TA, et al. Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task. Bone Marrow Transpl. 2016;51(10):1342\u20139.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"3059_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/leu.2017.199","volume":"32","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wu DP, Liu QF, et al. Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for Haematopoietic transplants. Leukemia. 2018;32(2):492\u20138.","journal-title":"Leukemia"},{"issue":"2","key":"3059_CR40","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","volume":"7","author":"O Penack","year":"2020","unstructured":"Penack O, Marchetti M, Ruutu T, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European society for blood and marrow transplantation. Lancet Haematol. 2020;7(2):e157\u201367.","journal-title":"Lancet Haematol"},{"issue":"5","key":"3059_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbmt.2014.02.003","volume":"20","author":"AC Yeh","year":"2014","unstructured":"Yeh AC, Brunner AM, Spitzer TR, et al. Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20(5):730\u20134.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"3059_CR42","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3324\/haematol.2019.228668","volume":"105","author":"O Penack","year":"2020","unstructured":"Penack O, Peczynski C, van der Werf S, et al. Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT transplant complication working party. Haematologica. 2020;105(7):1977\u201383.","journal-title":"Haematologica"},{"key":"3059_CR43","doi-asserted-by":"publisher","first-page":"620682","DOI":"10.1155\/2014\/620682","volume":"2014","author":"I Garcia Cadenas","year":"2014","unstructured":"Garcia Cadenas I, Valcarcel D, Martino R, et al. Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation. Mediators Inflamm. 2014;2014:620682.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"3059_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/bmt.2013.139","volume":"49","author":"JR Rogosheske","year":"2014","unstructured":"Rogosheske JR, Fargen AD, DeFor TE, et al. Higher therapeutic csa levels early post transplantation reduce risk of acute GVHD and improves survival. Bone Marrow Transpl. 2014;49(1):122\u20135.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"3059_CR45","doi-asserted-by":"publisher","first-page":"e0213913","DOI":"10.1371\/journal.pone.0213913","volume":"14","author":"EA de Kort","year":"2019","unstructured":"de Kort EA, de Lil HS, Bremmers MEJ, et al. Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation. PLoS ONE. 2019;14(3):e0213913.","journal-title":"PLoS ONE"},{"issue":"1","key":"3059_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","volume":"25","author":"P Royston","year":"2006","unstructured":"Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad Idea. Stat Med. 2006;25(1):127\u201341.","journal-title":"Stat Med"},{"issue":"9","key":"3059_CR47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/sim.3841","volume":"29","author":"L Desquilbet","year":"2010","unstructured":"Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037\u201357.","journal-title":"Stat Med"},{"issue":"10","key":"3059_CR48","first-page":"1169","volume":"54","author":"Y Wei","year":"2020","unstructured":"Wei Y, Zhou JH, Zhang ZW, et al. [Application of restricted cube spline in Cox regression model]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(10):1169\u201373.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"12","key":"3059_CR49","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","volume":"6","author":"K Bhaskaran","year":"2018","unstructured":"Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944\u201353.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3059_CR50","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1038\/s41598-020-60799-5","volume":"10","author":"M Greenland","year":"2020","unstructured":"Greenland M, Knuiman MW, Hung J, et al. Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships. Sci Rep. 2020;10(1):4315.","journal-title":"Sci Rep"},{"issue":"6","key":"3059_CR51","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/bmt.2009.299","volume":"45","author":"AJ Willemze","year":"2010","unstructured":"Willemze AJ, Press RR, Lankester AC, Egeler RM, den Hartigh J, Vossen JM. CsA exposure is associated with acute GVHD and relapse in children after SCT. Bone Marrow Transpl. 2010;45(6):1056\u201361.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"3059_CR52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481\u2013508.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3059_CR53","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1038\/s41467-023-43372-2","volume":"14","author":"E Bayraktar","year":"2023","unstructured":"Bayraktar E, Graf T, Ayuk FA, et al. Data-driven grading of acute graft-versus-host disease. Nat Commun. 2023;14(1):7799.","journal-title":"Nat Commun"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03059-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:09:12Z","timestamp":1751375352000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-03059-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03059-8","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work was conducted in compliance with Institutional Review Board\/Human Subjects Research Committee requirements. The study was approved by the Health Authority Ethics Committee of the First Affiliated Hospital of Soochow University and was performed in accordance with the Declaration of Helsinki (2019010). Due to the retrospective nature, informed consent was waived by an Institutional Review Board in this study. The name of Institutional Review Board: Health Authority Ethics Committee of the First Affiliated Hospital of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}